Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is nifedipine phototoxic?

M Guarrera1, A Parodi, A Rebora

  • 1Department of Dermatology, University of Genoa, Italy.

Photodermatology, Photoimmunology & Photomedicine
|February 1, 1990
PubMed
Summary

Nifedipine phototoxicity, suggested by limited clinical data, was confirmed in laboratory tests. The drug demonstrated measurable phototoxicity at concentrations higher than typically found in the bloodstream.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salt dependent aquagenic urticaria: nine new cases and proposal for a diagnostic work-up.

European annals of allergy and clinical immunology·2024
Same author

Gender differences in adult atopic dermatitis and clinical implication: Results from a nationwide multicentre study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Long-term clinical efficacy and safety of ixekizumab for psoriatic patients: a single-center experience.

European review for medical and pharmacological sciences·2023
Same author

Condylomata Lata and Papular Rash of Secondary Syphilis.

Actas dermo-sifiliograficas·2023
Same author

Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study.

Expert opinion on biological therapy·2023
Same author

Psoriasis patients' characteristics associated with high PASI response to tildrakizumab: an international dual center study.

European review for medical and pharmacological sciences·2022

Area of Science:

  • Pharmacology
  • Photobiology
  • Toxicology

Background:

  • Clinical evidence for nifedipine phototoxicity is limited and anecdotal.
  • Previous studies relied on uncontrolled observations, lacking rigorous scientific validation.

Observation:

  • Nifedipine's phototoxicity was investigated using in vitro photohemolysis and Candida albicans assays.
  • The study aimed to provide objective, quantitative data on nifedipine's photosensitizing potential.

Findings:

  • Nifedipine exhibited measurable phototoxicity in vitro at concentrations of 10 and 100 micrograms/ml.
  • These tested concentrations were significantly higher than the typical in vivo blood levels (0.1 microgram/ml) achieved by the drug.

Implications:

  • These findings suggest a potential, though perhaps low, risk of nifedipine-induced phototoxicity in patients.
  • Further research may be warranted to correlate in vitro findings with clinical outcomes and establish definitive risk levels.

Related Experiment Videos